Minsheng Health: Tartaric acid valsartan tablets and minoxidil lotion are expected to be launched for sale in the third quarter.

Minsheng Health stated at the earnings briefing on May 13 that the company's product aluminum magnesium carbonate suspension will be launched for sale by the end of 2024. The two newly approved products, paroxetine tartrate tablets and minoxidil topical solution, are currently in the packaging design and production preparation stage, with an expected launch for sale in the third quarter.

View Original
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments